Table 1.
The parameters correlating the expression of miR-588 and associated clinicopathologic features observed in GC patients (N=67)
Clinical parameters | Number of cases | Level of expression | P-value | |
---|---|---|---|---|
High miR-588 (31) | Low miR-588 (36) | |||
Gender Male Female |
46 21 |
21 10 |
25 11 |
0.751 |
Age of patients (years) <60 ≥60 |
24 43 |
11 20 |
14 22 |
0.625 |
Size of tumor (cm) <5 ≥5 |
53 14 |
25 6 |
27 9 |
0.501 |
Type Intestinal Diffuse |
54 13 |
19 12 |
30 6 |
0.312 |
TNM stage I+II III+IV |
17 50 |
10 21 |
5 31 |
0.005* |
Lymph node metastasis Present Absent |
48 19 |
17 14 |
30 6 |
0.002* |
Metastasis type Distant metastasis Nondistant metastasis |
09 58 |
03 28 |
06 30 |
0.008* |
Note:
P<0.05.
Abbreviation: GC, gastric cancer.